This is the new MLex platform. Existing customers should continue to access MLex here until migrated to the new platform. For any migration queries, please contact Customer Services or your Account Manager.

FTC should scrutinize oncology deals, US Senator Warren says

( October 29, 2024, 18:18 GMT | Official Statement) -- MLex Summary: US Senator Elizabeth Warren urged the US Federal Trade Commission to "closely scrutinize" a pair of oncology deals. McKesson Corp.'s proposed $2.49 billion acquisition of Core Ventures and Cardinal Health's $1.1 billion proposed acquisition of a controlling stake in Intergrated Oncology would continue consolidation in the market for oncology care, Warren said in a letter to FTC Chair Lina Khan. “These deals threaten to limit competition by opening the door for Cardinal and McKesson to expand their control of the already highly-concentrated oncology market by restricting affiliated oncology practices from contracting with rival drug wholesalers,” Warren wrote....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections